The experts say clinical vigilance is advisable because of the higher threat of malignancies for a period of 3.5 to 8.5 years, following termination of HRT.. Malignancy risk from HRT remains to be long after treatment has stopped The results of a new study show that the chance of cancer associated with Hormone Replacement Therapy continues lengthy after a woman stops taking it. In 2002 the Women’s Wellness Initiative study was stopped following a discovery of a significant increased risk of breast cancer and heart and artery disease in females assigned HRT. The trial had been running for about five years and involved 16,608 healthy post-menopausal women with the average age of 63, who were either given a combination oestrogen/progestin hormone alternative treatment or an inactive placebo.In 2012, the Task Force also formally suggested against routine PSA screeningfor prostate cancer tumor in healthy old adults. The panel said the risk of the blood check spotting a tumor as well slow-growing to ever result in a issue but may result in biopsy or surgery outweighed the cancers preventing benefits of the blood test. The American Urological Association said it had been outraged and the Task Force was doing men a disservice, arguing a PSA check provides useful information regarding pre-treatment and risk when interpreted correctly. Dr. Otis Brawley, chief medical officer of the American Cancers Society, told HealthDay that regardless of the misunderstandings that may arise, he thinks it is important for a patient to know information about dangers and benefits and have their doctors questions.